Universitat de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2024

  1. Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis

    Journal of Headache and Pain, Vol. 25, Núm. 1